Yojana Gadiya

Page 1846. In the published article, Figure 3 contained an error: the middle panel (Hepatotoxicity) was inadvertently duplicated from the left panel (CYP450 Toxicity) during the final revision process. The correct version of Figure 3 is provided here. This correction does not affect any p-value calculations, toxicity assessments, or the study’s conclusions. The authors apologize for any confusion it may have caused.

Abstract Repurposing of existing drugs for new indications has attracted substantial attention owing to its potential to accelerate drug development and reduce costs. Hundreds of computational resources such as databases and predictive platforms have been developed that can be applied for drug repurposing, making it challenging to select the right resource for a specific drug repurposing project.

1. Introduction Click to copy section linkSection link copied! Since their discovery, antibiotics have been primarily used to treat bacterial infections due to their ease of administration and potent antibacterial activity. (1) However, decades of liberal antibiotic use have led to a significant loss of effective treatment options. There is growing evidence that antimicrobial resistance (AMR) is an emerging threat to human health worldwide.